HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Expression of Ki-67 and PCNA as proliferating markers in prostate cancer.

Abstract
Prostate carcinoma (PCa) is the most common male cancer in industrialized societies and represents a serious public health problem. The aim of our study was the immunohistochemical evaluation of Ki-67 and proliferating cell nuclear antigen (PCNA) expression in prostate cancer (PCa) following radical prostatectomy and analysis of its relationship to chosen anatomo-clinical and morfological parameters of the tumours. Archival sections from 28 PCas were immunostained with monoclonal antibodies against Ki-67, and proliferating cell nuclear antigen (PCNA). Immunolocalization of Ki-67 and PCNA was performed using LSAB method. No statistically significant correlation was found between the expression of Ki-67, PCNA and preoperative PSA level, lymph node metastases, capsular penetration, seminal vesicle invasive and positive or negative surgical resection margins. However, a strong statistically significant correlation between Ki-67 positive and T stage was found. We also found relationship between Gleason score 7 or above and high expression of Ki-67 and PCNA in prostate cancers (p < 0.004, p < 0.02 respectively). These results suggest that PCNA and especially Ki-67 may be useful as tumour markers in prostate carcinoma, but further studies on larger group are required.
AuthorsMarian Sulik, Katarzyna Guzińska-Ustymowicz
JournalRoczniki Akademii Medycznej w Bialymstoku (1995) (Rocz Akad Med Bialymst) Vol. 47 Pg. 262-9 ( 2002) Poland
PMID12533969 (Publication Type: Comparative Study, Journal Article)
Chemical References
  • Biomarkers, Tumor
  • Ki-67 Antigen
  • Proliferating Cell Nuclear Antigen
Topics
  • Adenocarcinoma (pathology, surgery)
  • Aged
  • Biomarkers, Tumor (analysis)
  • Biopsy, Needle
  • Cohort Studies
  • Humans
  • Immunohistochemistry
  • Ki-67 Antigen (analysis)
  • Male
  • Middle Aged
  • Probability
  • Prognosis
  • Proliferating Cell Nuclear Antigen (analysis)
  • Prostatectomy
  • Prostatic Neoplasms (pathology, surgery)
  • Sensitivity and Specificity

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: